IP Library Granted Patent US 10,155,939
Granted Patent B1
US 10,155,939 · App. 15/623,756 · Granted Dec 18, 2018

Method for performing multiple enzyme reactions in a single tube

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,155,939
App. No.
15/623,756
Granted
Dec 18, 2018
Kind
B1
Abstract

Among other things, a method for performing multiple enzyme reactions in a single tube is provided. In some embodiments, the method may comprise producing a reaction mix comprising a thermolabile UDG, an AP lyase and DNA fragments that comprise one or more uracil residues, incubating the reaction mix at a relatively low temperature to cleave fragments at the one or more uracil residues, raising the temperature of the reaction mix to a relatively high temperature to inactivate the thermolabile UDG; and deaminating the fragments, thereby converting any cytosine in the fragments of DNA to uracil.

Claims (16)

1. A method for performing multiple enzyme reactions in a single tube, comprising:

(a) producing a reaction mix comprising a thermolabile uracil-DNA glycosylase (UDG), a DNA-(apurinic or apyrimidinic site) lyase (AP-lyase) and fragments of genomic or plasmid DNA that comprise one or more uracil residues;

(b) incubating the reaction mix at a temperature of below 40° C. to cleave the genomic or plasmid DNA fragments at the one or more uracil residues;

(c) raising the temperature of the reaction mix to at least 50° C. for a period of time to inactivate the thermolabile UDG; and

(d) after step (c) deaminating the fragments of genomic or plasmid DNA, thereby converting any cytosine in the fragments of genomic or plasmid DNA to uracil.

2. The method of claim 1 , wherein the fragments of genomic or plasmid DNA comprise an oligonucleotide, and wherein the oligonucleotide comprises the one or more uracil residues.

3. The method of claim 2 , wherein the oligonucleotide is an adapter ligated to at least one end of the genomic or plasmid fragments.

4. The method of claim 3 , wherein the adaptor is a loop adaptor.

5. The method of claim 1 , wherein AP lyase is also thermolabile.

6. The method of claim 1 , wherein AP lyase is Endonuclease III.

7. The method of claim 1 , wherein the deaminating is performed using a deaminase enzyme.

8. The method of claim 7 , wherein the deaminase enzyme has at least 90% sequence identity with SEQ ID NO:1 (APOBEC).

9. The method of claim 1 , wherein the deamination is performed by sodium bisulfite treatment.

10. The method of claim 1 , further comprising (e) amplifying the fragments of genomic or plasmid DNA.

11. The method of claim 10 , further comprising sequencing the amplification products.

12. The method of claim 11 , further comprising identifying the sites of methylcytosines and/or hydroxymethylcytosine residues in the fragments of genomic or plasmid DNA.

Assignments (2)
NOTICE OF GRANT OF SECURITY INTEREST IN PATENTS Recorded Sep 27, 2023
From: NEW ENGLAND BIOLABS, INC.
To: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 065044/0729 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 22, 2017
From: VAISVILA, ROMUALDAS; HIGGINS, LAUREN; LUCK, ASHLEY
To: NEW ENGLAND BIOLABS, INC.
Reel/Frame 042789/0893 →
Cited By (7)
US 12,291,742 US 12,331,346 US 12,338,489 US 12,467,082 US 12,467,087 US 12,601,006 US 12,630,866